ttr Search Results


m pneumoniae fh reference strain  (ATCC)
94
ATCC m pneumoniae fh reference strain
M Pneumoniae Fh Reference Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m pneumoniae fh reference strain/product/ATCC
Average 94 stars, based on 1 article reviews
m pneumoniae fh reference strain - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
ttr cre  (Addgene inc)
92
Addgene inc ttr cre
Ttr Cre, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ttr cre/product/Addgene inc
Average 92 stars, based on 1 article reviews
ttr cre - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
microplate rack for incubator shaker  (Eppendorf AG)
94
Eppendorf AG microplate rack for incubator shaker

Microplate Rack For Incubator Shaker, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microplate rack for incubator shaker/product/Eppendorf AG
Average 94 stars, based on 1 article reviews
microplate rack for incubator shaker - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
plasmid 11643  (Addgene inc)
93
Addgene inc plasmid 11643

Plasmid 11643, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmid 11643/product/Addgene inc
Average 93 stars, based on 1 article reviews
plasmid 11643 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
akt1  (Addgene inc)
93
Addgene inc akt1
Figure 6. Deletion of Pericyte-b3-Integrin Enhances Tumor Cell Growth via Pericyte-pAkt-p65-Regulated Cytokine Production (A) Western blot analysis of b3-null pericytes with CRISPR-Cas9 deletion of <t>Akt1</t> (b3-null;AktKO PC) or HGFR (b3-null;HGFRKO PC) compared with b3-null;Cas9 controls. Hsc70, loading control. Blots representative of 3 separate experiments. Bar charts, average densitometric analysis relative to loading controls (n = 3 experimental repeats). (B) B16F0 cell survival after exposure to conditioned media from b3-null;AktKO, b3-null;HGFRKO, or b3-null;Cas9 pericytes (n = 16 technical replicates for 2 separate experiments). (C) Tumor growth in WT mice injected subcutaneously with either B16F0 cells plus b3-null;Cas9 pericytes or B16F0 plus b3-null;AktKO pericytes at 1:8 ratio (n = 10 per group). (D) Western blot analysis using mock- and Ik-Ba-SR-transfected WT or b3-null pericyte lysates. HSC70, loading control. (E) Protein-profiler cytokine arrays. Quantitation of fold difference in cytokine expression between mock- and Ik-Ba-SR-transfected b3-null pericytes (n = 4 dots from 2 independent experiments). (F) Conditioned media from mock- and Ik-Ba-SR-transfected b3-null pericytes were applied to B16F0, B16F10, and LLC cells and cell survival measured by MTS assay. Bar charts, means ± SEM relative to tumor cells treated with conditioned media from mock-transfected b3-null pericytes (n = 3 experimental repeats).
Akt1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/akt1/product/Addgene inc
Average 93 stars, based on 1 article reviews
akt1 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
paper n a plvpt ttr krab szulc  (Addgene inc)
92
Addgene inc paper n a plvpt ttr krab szulc
Figure 6. Deletion of Pericyte-b3-Integrin Enhances Tumor Cell Growth via Pericyte-pAkt-p65-Regulated Cytokine Production (A) Western blot analysis of b3-null pericytes with CRISPR-Cas9 deletion of <t>Akt1</t> (b3-null;AktKO PC) or HGFR (b3-null;HGFRKO PC) compared with b3-null;Cas9 controls. Hsc70, loading control. Blots representative of 3 separate experiments. Bar charts, average densitometric analysis relative to loading controls (n = 3 experimental repeats). (B) B16F0 cell survival after exposure to conditioned media from b3-null;AktKO, b3-null;HGFRKO, or b3-null;Cas9 pericytes (n = 16 technical replicates for 2 separate experiments). (C) Tumor growth in WT mice injected subcutaneously with either B16F0 cells plus b3-null;Cas9 pericytes or B16F0 plus b3-null;AktKO pericytes at 1:8 ratio (n = 10 per group). (D) Western blot analysis using mock- and Ik-Ba-SR-transfected WT or b3-null pericyte lysates. HSC70, loading control. (E) Protein-profiler cytokine arrays. Quantitation of fold difference in cytokine expression between mock- and Ik-Ba-SR-transfected b3-null pericytes (n = 4 dots from 2 independent experiments). (F) Conditioned media from mock- and Ik-Ba-SR-transfected b3-null pericytes were applied to B16F0, B16F10, and LLC cells and cell survival measured by MTS assay. Bar charts, means ± SEM relative to tumor cells treated with conditioned media from mock-transfected b3-null pericytes (n = 3 experimental repeats).
Paper N A Plvpt Ttr Krab Szulc, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/paper n a plvpt ttr krab szulc/product/Addgene inc
Average 92 stars, based on 1 article reviews
paper n a plvpt ttr krab szulc - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
human ttr precursor cdna  (Addgene inc)
93
Addgene inc human ttr precursor cdna
Figure 6. Deletion of Pericyte-b3-Integrin Enhances Tumor Cell Growth via Pericyte-pAkt-p65-Regulated Cytokine Production (A) Western blot analysis of b3-null pericytes with CRISPR-Cas9 deletion of <t>Akt1</t> (b3-null;AktKO PC) or HGFR (b3-null;HGFRKO PC) compared with b3-null;Cas9 controls. Hsc70, loading control. Blots representative of 3 separate experiments. Bar charts, average densitometric analysis relative to loading controls (n = 3 experimental repeats). (B) B16F0 cell survival after exposure to conditioned media from b3-null;AktKO, b3-null;HGFRKO, or b3-null;Cas9 pericytes (n = 16 technical replicates for 2 separate experiments). (C) Tumor growth in WT mice injected subcutaneously with either B16F0 cells plus b3-null;Cas9 pericytes or B16F0 plus b3-null;AktKO pericytes at 1:8 ratio (n = 10 per group). (D) Western blot analysis using mock- and Ik-Ba-SR-transfected WT or b3-null pericyte lysates. HSC70, loading control. (E) Protein-profiler cytokine arrays. Quantitation of fold difference in cytokine expression between mock- and Ik-Ba-SR-transfected b3-null pericytes (n = 4 dots from 2 independent experiments). (F) Conditioned media from mock- and Ik-Ba-SR-transfected b3-null pericytes were applied to B16F0, B16F10, and LLC cells and cell survival measured by MTS assay. Bar charts, means ± SEM relative to tumor cells treated with conditioned media from mock-transfected b3-null pericytes (n = 3 experimental repeats).
Human Ttr Precursor Cdna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ttr precursor cdna/product/Addgene inc
Average 93 stars, based on 1 article reviews
human ttr precursor cdna - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
inducible system vector plvet ttr krab  (Addgene inc)
92
Addgene inc inducible system vector plvet ttr krab
Figure 6. Deletion of Pericyte-b3-Integrin Enhances Tumor Cell Growth via Pericyte-pAkt-p65-Regulated Cytokine Production (A) Western blot analysis of b3-null pericytes with CRISPR-Cas9 deletion of <t>Akt1</t> (b3-null;AktKO PC) or HGFR (b3-null;HGFRKO PC) compared with b3-null;Cas9 controls. Hsc70, loading control. Blots representative of 3 separate experiments. Bar charts, average densitometric analysis relative to loading controls (n = 3 experimental repeats). (B) B16F0 cell survival after exposure to conditioned media from b3-null;AktKO, b3-null;HGFRKO, or b3-null;Cas9 pericytes (n = 16 technical replicates for 2 separate experiments). (C) Tumor growth in WT mice injected subcutaneously with either B16F0 cells plus b3-null;Cas9 pericytes or B16F0 plus b3-null;AktKO pericytes at 1:8 ratio (n = 10 per group). (D) Western blot analysis using mock- and Ik-Ba-SR-transfected WT or b3-null pericyte lysates. HSC70, loading control. (E) Protein-profiler cytokine arrays. Quantitation of fold difference in cytokine expression between mock- and Ik-Ba-SR-transfected b3-null pericytes (n = 4 dots from 2 independent experiments). (F) Conditioned media from mock- and Ik-Ba-SR-transfected b3-null pericytes were applied to B16F0, B16F10, and LLC cells and cell survival measured by MTS assay. Bar charts, means ± SEM relative to tumor cells treated with conditioned media from mock-transfected b3-null pericytes (n = 3 experimental repeats).
Inducible System Vector Plvet Ttr Krab, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inducible system vector plvet ttr krab/product/Addgene inc
Average 92 stars, based on 1 article reviews
inducible system vector plvet ttr krab - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
rabbit pab  (Boster Bio)
92
Boster Bio rabbit pab
Figure 6. Deletion of Pericyte-b3-Integrin Enhances Tumor Cell Growth via Pericyte-pAkt-p65-Regulated Cytokine Production (A) Western blot analysis of b3-null pericytes with CRISPR-Cas9 deletion of <t>Akt1</t> (b3-null;AktKO PC) or HGFR (b3-null;HGFRKO PC) compared with b3-null;Cas9 controls. Hsc70, loading control. Blots representative of 3 separate experiments. Bar charts, average densitometric analysis relative to loading controls (n = 3 experimental repeats). (B) B16F0 cell survival after exposure to conditioned media from b3-null;AktKO, b3-null;HGFRKO, or b3-null;Cas9 pericytes (n = 16 technical replicates for 2 separate experiments). (C) Tumor growth in WT mice injected subcutaneously with either B16F0 cells plus b3-null;Cas9 pericytes or B16F0 plus b3-null;AktKO pericytes at 1:8 ratio (n = 10 per group). (D) Western blot analysis using mock- and Ik-Ba-SR-transfected WT or b3-null pericyte lysates. HSC70, loading control. (E) Protein-profiler cytokine arrays. Quantitation of fold difference in cytokine expression between mock- and Ik-Ba-SR-transfected b3-null pericytes (n = 4 dots from 2 independent experiments). (F) Conditioned media from mock- and Ik-Ba-SR-transfected b3-null pericytes were applied to B16F0, B16F10, and LLC cells and cell survival measured by MTS assay. Bar charts, means ± SEM relative to tumor cells treated with conditioned media from mock-transfected b3-null pericytes (n = 3 experimental repeats).
Rabbit Pab, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit pab/product/Boster Bio
Average 92 stars, based on 1 article reviews
rabbit pab - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
lentiviral vector 32  (Addgene inc)
92
Addgene inc lentiviral vector 32
Figure 6. Deletion of Pericyte-b3-Integrin Enhances Tumor Cell Growth via Pericyte-pAkt-p65-Regulated Cytokine Production (A) Western blot analysis of b3-null pericytes with CRISPR-Cas9 deletion of <t>Akt1</t> (b3-null;AktKO PC) or HGFR (b3-null;HGFRKO PC) compared with b3-null;Cas9 controls. Hsc70, loading control. Blots representative of 3 separate experiments. Bar charts, average densitometric analysis relative to loading controls (n = 3 experimental repeats). (B) B16F0 cell survival after exposure to conditioned media from b3-null;AktKO, b3-null;HGFRKO, or b3-null;Cas9 pericytes (n = 16 technical replicates for 2 separate experiments). (C) Tumor growth in WT mice injected subcutaneously with either B16F0 cells plus b3-null;Cas9 pericytes or B16F0 plus b3-null;AktKO pericytes at 1:8 ratio (n = 10 per group). (D) Western blot analysis using mock- and Ik-Ba-SR-transfected WT or b3-null pericyte lysates. HSC70, loading control. (E) Protein-profiler cytokine arrays. Quantitation of fold difference in cytokine expression between mock- and Ik-Ba-SR-transfected b3-null pericytes (n = 4 dots from 2 independent experiments). (F) Conditioned media from mock- and Ik-Ba-SR-transfected b3-null pericytes were applied to B16F0, B16F10, and LLC cells and cell survival measured by MTS assay. Bar charts, means ± SEM relative to tumor cells treated with conditioned media from mock-transfected b3-null pericytes (n = 3 experimental repeats).
Lentiviral Vector 32, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lentiviral vector 32/product/Addgene inc
Average 92 stars, based on 1 article reviews
lentiviral vector 32 - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
plvuth  (Addgene inc)
90
Addgene inc plvuth
Figure 6. Deletion of Pericyte-b3-Integrin Enhances Tumor Cell Growth via Pericyte-pAkt-p65-Regulated Cytokine Production (A) Western blot analysis of b3-null pericytes with CRISPR-Cas9 deletion of <t>Akt1</t> (b3-null;AktKO PC) or HGFR (b3-null;HGFRKO PC) compared with b3-null;Cas9 controls. Hsc70, loading control. Blots representative of 3 separate experiments. Bar charts, average densitometric analysis relative to loading controls (n = 3 experimental repeats). (B) B16F0 cell survival after exposure to conditioned media from b3-null;AktKO, b3-null;HGFRKO, or b3-null;Cas9 pericytes (n = 16 technical replicates for 2 separate experiments). (C) Tumor growth in WT mice injected subcutaneously with either B16F0 cells plus b3-null;Cas9 pericytes or B16F0 plus b3-null;AktKO pericytes at 1:8 ratio (n = 10 per group). (D) Western blot analysis using mock- and Ik-Ba-SR-transfected WT or b3-null pericyte lysates. HSC70, loading control. (E) Protein-profiler cytokine arrays. Quantitation of fold difference in cytokine expression between mock- and Ik-Ba-SR-transfected b3-null pericytes (n = 4 dots from 2 independent experiments). (F) Conditioned media from mock- and Ik-Ba-SR-transfected b3-null pericytes were applied to B16F0, B16F10, and LLC cells and cell survival measured by MTS assay. Bar charts, means ± SEM relative to tumor cells treated with conditioned media from mock-transfected b3-null pericytes (n = 3 experimental repeats).
Plvuth, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plvuth/product/Addgene inc
Average 90 stars, based on 1 article reviews
plvuth - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
anti ttr  (Proteintech)
94
Proteintech anti ttr
Figure 6. Deletion of Pericyte-b3-Integrin Enhances Tumor Cell Growth via Pericyte-pAkt-p65-Regulated Cytokine Production (A) Western blot analysis of b3-null pericytes with CRISPR-Cas9 deletion of <t>Akt1</t> (b3-null;AktKO PC) or HGFR (b3-null;HGFRKO PC) compared with b3-null;Cas9 controls. Hsc70, loading control. Blots representative of 3 separate experiments. Bar charts, average densitometric analysis relative to loading controls (n = 3 experimental repeats). (B) B16F0 cell survival after exposure to conditioned media from b3-null;AktKO, b3-null;HGFRKO, or b3-null;Cas9 pericytes (n = 16 technical replicates for 2 separate experiments). (C) Tumor growth in WT mice injected subcutaneously with either B16F0 cells plus b3-null;Cas9 pericytes or B16F0 plus b3-null;AktKO pericytes at 1:8 ratio (n = 10 per group). (D) Western blot analysis using mock- and Ik-Ba-SR-transfected WT or b3-null pericyte lysates. HSC70, loading control. (E) Protein-profiler cytokine arrays. Quantitation of fold difference in cytokine expression between mock- and Ik-Ba-SR-transfected b3-null pericytes (n = 4 dots from 2 independent experiments). (F) Conditioned media from mock- and Ik-Ba-SR-transfected b3-null pericytes were applied to B16F0, B16F10, and LLC cells and cell survival measured by MTS assay. Bar charts, means ± SEM relative to tumor cells treated with conditioned media from mock-transfected b3-null pericytes (n = 3 experimental repeats).
Anti Ttr, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ttr/product/Proteintech
Average 94 stars, based on 1 article reviews
anti ttr - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

Image Search Results


Journal: STAR Protocols

Article Title: Streamlined high-throughput cloning protocol to generate arrayed mutant libraries

doi: 10.1016/j.xpro.2022.101930

Figure Lengend Snippet:

Article Snippet: Microplate Rack for Incubator Shaker , Eppendorf , Cat#TTR-221.

Techniques: Virus, Recombinant, Plasmid Preparation, Mutagenesis, Software, Sterility, Aerosol

Figure 6. Deletion of Pericyte-b3-Integrin Enhances Tumor Cell Growth via Pericyte-pAkt-p65-Regulated Cytokine Production (A) Western blot analysis of b3-null pericytes with CRISPR-Cas9 deletion of Akt1 (b3-null;AktKO PC) or HGFR (b3-null;HGFRKO PC) compared with b3-null;Cas9 controls. Hsc70, loading control. Blots representative of 3 separate experiments. Bar charts, average densitometric analysis relative to loading controls (n = 3 experimental repeats). (B) B16F0 cell survival after exposure to conditioned media from b3-null;AktKO, b3-null;HGFRKO, or b3-null;Cas9 pericytes (n = 16 technical replicates for 2 separate experiments). (C) Tumor growth in WT mice injected subcutaneously with either B16F0 cells plus b3-null;Cas9 pericytes or B16F0 plus b3-null;AktKO pericytes at 1:8 ratio (n = 10 per group). (D) Western blot analysis using mock- and Ik-Ba-SR-transfected WT or b3-null pericyte lysates. HSC70, loading control. (E) Protein-profiler cytokine arrays. Quantitation of fold difference in cytokine expression between mock- and Ik-Ba-SR-transfected b3-null pericytes (n = 4 dots from 2 independent experiments). (F) Conditioned media from mock- and Ik-Ba-SR-transfected b3-null pericytes were applied to B16F0, B16F10, and LLC cells and cell survival measured by MTS assay. Bar charts, means ± SEM relative to tumor cells treated with conditioned media from mock-transfected b3-null pericytes (n = 3 experimental repeats).

Journal: Cell

Article Title: Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells.

doi: 10.1016/j.cell.2020.02.003

Figure Lengend Snippet: Figure 6. Deletion of Pericyte-b3-Integrin Enhances Tumor Cell Growth via Pericyte-pAkt-p65-Regulated Cytokine Production (A) Western blot analysis of b3-null pericytes with CRISPR-Cas9 deletion of Akt1 (b3-null;AktKO PC) or HGFR (b3-null;HGFRKO PC) compared with b3-null;Cas9 controls. Hsc70, loading control. Blots representative of 3 separate experiments. Bar charts, average densitometric analysis relative to loading controls (n = 3 experimental repeats). (B) B16F0 cell survival after exposure to conditioned media from b3-null;AktKO, b3-null;HGFRKO, or b3-null;Cas9 pericytes (n = 16 technical replicates for 2 separate experiments). (C) Tumor growth in WT mice injected subcutaneously with either B16F0 cells plus b3-null;Cas9 pericytes or B16F0 plus b3-null;AktKO pericytes at 1:8 ratio (n = 10 per group). (D) Western blot analysis using mock- and Ik-Ba-SR-transfected WT or b3-null pericyte lysates. HSC70, loading control. (E) Protein-profiler cytokine arrays. Quantitation of fold difference in cytokine expression between mock- and Ik-Ba-SR-transfected b3-null pericytes (n = 4 dots from 2 independent experiments). (F) Conditioned media from mock- and Ik-Ba-SR-transfected b3-null pericytes were applied to B16F0, B16F10, and LLC cells and cell survival measured by MTS assay. Bar charts, means ± SEM relative to tumor cells treated with conditioned media from mock-transfected b3-null pericytes (n = 3 experimental repeats).

Article Snippet: SgRNAs were designed using the CRISPOR algorithm (http://crispor.tefor.net). sgRNA sequences targeting TIMP-1 (Gene ID: 21857), CXCL1 (Gene ID: 14825), CCL2 (Gene ID: 20296), Akt1 (Gene ID: 11651), and HGFR (Met) (Gene ID: 17295) (see Table S1) were cloned into the pLenti-CRISPR–EGFP plasmid (Addgene-#75159) using BsmBI enzyme site.

Techniques: Western Blot, CRISPR, Control, Injection, Transfection, Quantitation Assay, Expressing, MTS Assay